Author(s):
Anjali Athanerey, Neha Rani Verma, Piyush Bhargava, P K Patra, Awanish Kumar
Email(s):
pkp1964@yahoo.co.in , drawanishkr@gmail.com , awanik.bt@nitrr.ac.in
DOI:
10.5958/0974-360X.2021.00068.8 
Address:
Anjali Athanerey1, Neha Rani Verma2, Piyush Bhargava3, P K Patra4*, Awanish Kumar1*
1Department of Biotechnology, National Institute of Technology Raipur, Chhattisgarh.
2Department of Biochemistry AIIMS Raipur, Chhattisgarh.
3Department of Biochemistry, Pt JNM Medical College Raipur, Chhattisgarh.
4Dean, Department of Biochemistry, Pt. J.N.M. Medical College, Raipur, Chhattisgarh.
*Corresponding Author
Published In:
Volume - 14,
Issue - 1,
Year - 2021
ABSTRACT:
Severity of non-healing ulcers depends upon both local and systemic factors. Available treatment options like wound dressing, compression therapy, and others have improved clinical outcomes, but chronic wounds continue to exist as the major clinical issues in the patients. As per previous reports, introduction of mesenchymal stem cells has a better treatment option for regenerative therapy. The purpose of this research work was to examine the histopathological and cellular level changes in chronic wound to access whether the application of autologous mesenchymal stem cells improved the wound site environment. Tissue samples from debrided tissue of the chronic wounds were taken before and after the mesenchymal stem cell treatment. Further histopathology and confocal microscopy analysis were also done. Characterization of MSCs was carried out by flow cytometer. We observed that autologous mesenchymal stem cell treatment improved the wound site environment Histopathological and cellular level changes supported the evidence that mesenchymal stem cell treatment reduces the inflammatory damage and facilitating wound area with angiogenesis. Autologous MSCs are positive for CD90, CD105 markers and negative for CD34, CD45 markers. We have found positive results for the treatment of chronic non-healing wounds using mesenchymal stem cells. It is suggested that autologous mesenchymal stem cell treatment has a positive impact on chronic wound healing. Further analysis should be performed to signify some more interactions among cells to facilitate chronic wound healing that would be a silver lining in regenerative medicine.
Cite this article:
Anjali Athanerey, Neha Rani Verma, Piyush Bhargava, P K Patra, Awanish Kumar. Mesenchymal stem cells prove a significant role in Chronic non-healing ulcer progressive healing. Research J. Pharm. and Tech. 2021; 14(1):373-377. doi: 10.5958/0974-360X.2021.00068.8
Cite(Electronic):
Anjali Athanerey, Neha Rani Verma, Piyush Bhargava, P K Patra, Awanish Kumar. Mesenchymal stem cells prove a significant role in Chronic non-healing ulcer progressive healing. Research J. Pharm. and Tech. 2021; 14(1):373-377. doi: 10.5958/0974-360X.2021.00068.8 Available on: https://rjptonline.org/AbstractView.aspx?PID=2021-14-1-68
REFERENCES:
1. Ribeiro J, Pereira T, Amorim I, Caseiro AR, Lopes MA, Lima J, Gartner A, Santos JD, Bártolo PJ, Rodrigues JM, Mauricio AC, Luís AL. Cell therapy with human MSCs isolated from the umbilical cord wharton jelly associated to a PVA membrane in the treatment of chronic skin wounds. Int. J. Med. Sci. 2014;11(10): 979–987.
2. Suthar M, Gupta S, Bukhari S, Ponemone V. Treatment of chronic non-healing ulcers using autologous platelet rich plasma: a case series. J. Biomed. Sci. 2017;24(1): 1–10.
3. Agale SV. Chronic Leg Ulcers : Epidemiology, Aetiopathogenesis , and Management. Ulcers. 2013; 2013:9.
4. Langer V. Leg ulcers: An Indian perspective. Indian Dermatol. Online J. 2014;5(4): 535.
5. K. N. Choudhary, Pradeep Soni RS. Comparative Study of Honey and Betadine in Chronic Ulcer Healing. J. Evid. based Med. Healthc. 2015;2(41): 6877–6882.
6. Rizzi SC, Upton Z, Bott K, Dargaville TR. Recent advances in dermal wound healing: biomedical device approaches. Expert Rev. Med. Devices. 2010 [cited 2016 Jun 30];7(1):143–54. Available from http://www.ncbi.nlm.nih.gov/pubmed/20021245
7. Lauritano D, Palmieri A, Vinci R, Azzi L, Taglabue A, Carinci F. Adipose derived stem cells: basic science fundaments and clinical application. An update. Minerva Stomatol. 2014 [cited 2016 Jun 30];63(7–8):273–81. Available from http://www.ncbi.nlm.nih.gov/pubmed/25299362
8. Maxson S, Lopez E a., Yoo D, Danilkovitch-Miagkova A, LeRoux M a. Concise Review: Role of Mesenchymal Stem Cells in Wound Repair. Stem Cells Transl. Med. 2012;1(2):142–149.
9. Chen JS, Wong VW, Gurtner GC. Therapeutic potential of bone marrow-derived mesenchymal stem cells for cutaneous wound healing. Front. Immunol. 2012;3(JUL):1–9.
10. George K. Turi, Virginia Donovan, Julie DiGregorio, Theresa M. Criscitelli, Benjamin Kashan, Stephan Barrientos, Jose Ramon Balingcongan, Scott Gorenstein HB. Major Histopathologic Diagnoses of Chronic Wounds. Adv. Skin Wound Care. 2016;29(8):376–382.
11. Johnson S, Rabinovitch P. Ex-vivo imaging of excised tissue using vital dyes and confocal microscopy. Curr. Protoc. Cytom. 2012:1–20.
12. Chong PP, Selvaratnam L, Abbas AA, Kamarul T. Human peripheral blood derived mesenchymal stem cells demonstrate similar characteristics and chondrogenic differentiation potential to bone marrow derived mesenchymal stem cells. J. Orthop. Res. 2012;30(4):634–642.
13. Trivanović D, Kocić J, Mojsilović S, Krstić A, Ilić V, Okić Djordjević I, Francisco Santibanez J, Jovčić G, Terzić M, Bugarski D. Mesenchymal stem cells isolated from peripheral blood and umbilical cord Wharton’s Jelly. Srp. Arh. Celok. Lek. 2013;141(3–4):178–186.
14. Luis Rodriguez-menocal, Marcela Salgado, Dwayne Ford EVB. Stimulation of Skin and Wound Fibroblast Migration by Mesenchymal Stem Cells Derived from Normal Donors and Chronic Wound Patients. Stem Cells Transl. Med. 2012;1:221–229.
15. Sanchez MC, Lancel S, Boulanger E, Neviere R. Targeting oxidative stress and mitochondrial dysfunction in the treatment of impaired wound healing: A systematic review. Antioxidants. 2018;7(8):1–14.
16. Weinheimer-Haus EM, Mirza RE, Koh TJ. Nod-like receptor protein-3 inflammasome plays an important role during early stages of wound healing. PLoS One. 2015;10(3):1–13.
17. Kunkemoeller B, Kyriakides TR. Redox Signaling in Diabetic Wound Healing Regulates Extracellular Matrix Deposition. Antioxidants Redox Signal. 2017;27(12):823–838.
18. André-Lévigne D, Modarressi A, Pepper MS, Pittet-Cuénod B. Reactive oxygen species and NOX enzymes are emerging as key players in cutaneous wound repair. Int. J. Mol. Sci. 2017;18(10).
19. Jabaut J, Ather JL, Taracanova A, Poynter ME, Ckless K. Mitochondria-targeted drugs enhance Nlrp3 inflammasome-dependent IL-1β secretion in association with alterations in cellular redox and energy status. Free Radic. Biol. Med. 2013;60:233–245.